skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Refinado por: Base de dados/Biblioteca: ClinicalKey remover Base de dados/Biblioteca: DOAJ Directory of Open Access Journals remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Clinical implications of the intrinsic molecular subtypes of breast cancer
Clinical implications of the intrinsic molecular subtypes of breast cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Clinical implications of the intrinsic molecular subtypes of breast cancer

Prat, Aleix ; Pineda, Estela ; Adamo, Barbara ; Galván, Patricia ; Fernández, Aranzazu ; Gaba, Lydia ; Díez, Marc ; Viladot, Margarita ; Arance, Ana ; Muñoz, Montserrat

Breast (Edinburgh), 2015-11, Vol.24, p.S26-S35 [Periódico revisado por pares]

Netherlands: Elsevier Ltd

Texto completo disponível

Citações Citado por
2
Phase II open-label study of bevacizumab combined with neoadjuvant anthracycline and taxane therapy for locally advanced breast cancer
Phase II open-label study of bevacizumab combined with neoadjuvant anthracycline and taxane therapy for locally advanced breast cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Phase II open-label study of bevacizumab combined with neoadjuvant anthracycline and taxane therapy for locally advanced breast cancer

Clavarezza, Matteo ; Turazza, Monica ; Aitini, Enrico ; Saracchini, Silvana ; Garrone, Ornella ; Durando, Antonio ; De Placido, Sabino ; Bisagni, Giancarlo ; Levaggi, Alessia ; Bighin, Claudia ; Restuccia, Eleonora ; Scalamogna, Roberto ; Galli, Anna ; Del Mastro, Lucia

Breast (Edinburgh), 2013-08, Vol.22 (4), p.470-475 [Periódico revisado por pares]

Netherlands: Elsevier Ltd

Texto completo disponível

Citações Citado por
3
Targeting immune pathways in breast cancer: review of the prognostic utility of TILs in early stage triple negative breast cancer (TNBC)
Targeting immune pathways in breast cancer: review of the prognostic utility of TILs in early stage triple negative breast cancer (TNBC)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Targeting immune pathways in breast cancer: review of the prognostic utility of TILs in early stage triple negative breast cancer (TNBC)

Blackley, Elizabeth F ; Loi, Sherene

Breast (Edinburgh), 2019-11, Vol.48 Suppl 1, p.S44-S48 [Periódico revisado por pares]

Netherlands

Texto completo disponível

Citações Citado por
4
Antibody-drug conjugates targeting TROP-2: Clinical development in metastatic breast cancer
Antibody-drug conjugates targeting TROP-2: Clinical development in metastatic breast cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Antibody-drug conjugates targeting TROP-2: Clinical development in metastatic breast cancer

Shastry, Mythili ; Jacob, Saya ; Rugo, Hope S. ; Hamilton, Erika

Breast (Edinburgh), 2022-12, Vol.66, p.169-177 [Periódico revisado por pares]

Netherlands: Elsevier Ltd

Texto completo disponível

Citações Citado por
5
Palliative systemic therapy and overall survival of 1,395 patients with advanced breast cancer – Results from the prospective German TMK cohort study
Palliative systemic therapy and overall survival of 1,395 patients with advanced breast cancer – Results from the prospective German TMK cohort study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Palliative systemic therapy and overall survival of 1,395 patients with advanced breast cancer – Results from the prospective German TMK cohort study

Fietz, Thomas ; Tesch, Hans ; Rauh, Jacqueline ; Boller, Emil ; Kruggel, Lisa ; Jänicke, Martina ; Marschner, Norbert

Breast (Edinburgh), 2017-08, Vol.34, p.122-130 [Periódico revisado por pares]

Netherlands: Elsevier Ltd

Texto completo disponível

Citações Citado por
6
PARP-inhibitors for BRCA1/2-related advanced HER2-negative breast cancer: A meta-analysis and GRADE recommendations by the Italian Association of Medical Oncology
PARP-inhibitors for BRCA1/2-related advanced HER2-negative breast cancer: A meta-analysis and GRADE recommendations by the Italian Association of Medical Oncology
Material Type:
Artigo 		Adicionar ao Meu Espaço

PARP-inhibitors for BRCA1/2-related advanced HER2-negative breast cancer: A meta-analysis and GRADE recommendations by the Italian Association of Medical Oncology

Miglietta, Federica ; Cinquini, Michela ; Dieci, Maria Vittoria ; Cortesi, Laura ; Criscitiello, Carmen ; Montemurro, Filippo ; Del Mastro, Lucia ; Zambelli, Alberto ; Biganzoli, Laura ; Levaggi, Alessia ; Delle Piane, Chiara ; Marchiò, Caterina ; Calabrese, Massimo ; Fortunato, Lucio ; Franco, Pierfrancesco ; Meduri, Bruno ; Fittipaldo, Veronica Andrea ; Gori, Stefania

Breast (Edinburgh), 2022-12, Vol.66, p.293-304 [Periódico revisado por pares]

Netherlands: Elsevier Ltd

Texto completo disponível

Citações Citado por
7
Novel folic acid-conjugated doxorubicin loaded β-lactoglobulin nanoparticles induce apoptosis in breast cancer cells
Novel folic acid-conjugated doxorubicin loaded β-lactoglobulin nanoparticles induce apoptosis in breast cancer cells
Material Type:
Artigo 		Adicionar ao Meu Espaço

Novel folic acid-conjugated doxorubicin loaded β-lactoglobulin nanoparticles induce apoptosis in breast cancer cells

Kayani, Zahra ; Bordbar, Abdol-Khalegh ; Firuzi, Omidreza

Biomedicine & pharmacotherapy, 2018-11, Vol.107, p.945-956 [Periódico revisado por pares]

France: Elsevier Masson SAS

Texto completo disponível

Citações Citado por
8
Anthracycline could be essential for triple-negative breast cancer: A randomised phase II study by the Kanagawa Breast Oncology Group (KBOG) 1101
Anthracycline could be essential for triple-negative breast cancer: A randomised phase II study by the Kanagawa Breast Oncology Group (KBOG) 1101
Material Type:
Artigo 		Adicionar ao Meu Espaço

Anthracycline could be essential for triple-negative breast cancer: A randomised phase II study by the Kanagawa Breast Oncology Group (KBOG) 1101

Narui, Kazutaka ; Ishikawa, Takashi ; Shimizu, Daisuke ; Yamada, Akimitsu ; Tanabe, Mikiko ; Sasaki, Takeshi ; Oba, Mari S. ; Morita, Satoshi ; Nawata, Shuichi ; Kida, Kumiko ; Mogaki, Masatoshi ; Doi, Takako ; Tsugawa, Koichiro ; Ogata, Haruki ; Ota, Tomohiko ; Kosaka, Yoshimasa ; Sengoku, Norihiko ; Kuranami, Masaru ; Niikura, Naoki ; Saito, Yuki ; Suzuki, Yasuhiro ; Suto, Akihiko ; Arioka, Hitoshi ; Chishima, Takashi ; Ichikawa, Yasushi ; Endo, Itaru ; Tokuda, Yutaka

Breast (Edinburgh), 2019-10, Vol.47, p.1-9 [Periódico revisado por pares]

Netherlands: Elsevier Ltd

Texto completo disponível

Citações Citado por
9
Adjuvant chemotherapy for resected triple negative breast cancer patients: A network meta-analysis
Adjuvant chemotherapy for resected triple negative breast cancer patients: A network meta-analysis
Material Type:
Artigo 		Adicionar ao Meu Espaço

Adjuvant chemotherapy for resected triple negative breast cancer patients: A network meta-analysis

Petrelli, Fausto ; Bertaglia, Valentina ; Parati, Maria Chiara ; Borgonovo, Karen ; De Silva, Pushpamali ; Luciani, Andrea ; Novello, Silvia ; Scartozzi, Mario ; Emens, Leisha A. ; Solinas, Cinzia

Breast (Edinburgh), 2023-02, Vol.67, p.8-13 [Periódico revisado por pares]

Netherlands: Elsevier Ltd

Texto completo disponível

Citações Citado por
10
Best of the year: Advanced breast cancer in 2023
Best of the year: Advanced breast cancer in 2023
Material Type:
Artigo 		Adicionar ao Meu Espaço

Best of the year: Advanced breast cancer in 2023

Schlam, Ilana ; Chavez-MacGregor, Mariana

Breast (Edinburgh), 2024-04, Vol.74, p.103677-103677, Article 103677 [Periódico revisado por pares]

Netherlands: Elsevier Ltd

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Data de Publicação 

De até
Refinar
  1. Antes de1993  (8)
  2. 1993Até2000  (14)
  3. 2001Até2007  (207)
  4. 2008Até2015  (468)
  5. Após 2015  (636)
  6. Mais opções open sub menu

Idioma 

  1. Inglês  (1.329)
  2. Japonês  (106)
  3. Português  (9)
  4. Espanhol  (4)
  5. Norueguês  (1)
  6. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.